Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction
Chemical Communications · 2024 · 60 (63) · 8228-8231
DOI: 10.1039/d4cc01249f ↗At a glance
Journal article in Chemical Communications, 2024. Written by Deanne Hayward and 4 co-authors. Institution: School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR47TJ, UK. A.Beekman@uea.ac.uk. Major MEDLINE topics: Azo Compounds, Peptides, Programmed Cell Death 1 Receptor, B7-H1 Antigen. Cited 6 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 3.0). Funded by: Royal Society, Biotechnology and Biological Sciences Research Council.
Abstract (original language)
A photoswitch peptide that binds to PD-1/PD-L1 only in the cis conformation, allowing for external control of the immune checkpoint interaction.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR47TJ, UK. A.Beekman@uea.ac.uk.
ORCID profiles: Zoë R Goddard, Mark Searcey, Andrew M Beekman
Funding
- Royal Society
- Biotechnology and Biological Sciences Research Council
Cite
APA
Hayward, D., Goddard, Z. R., Cominetti, M. M. D., Searcey, M., & Beekman, A. M. (2024). Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical Communications, 60(63), 8228-8231. https://doi.org/10.1039/d4cc01249f
Vancouver
Hayward D, Goddard ZR, Cominetti MMD, Searcey M, Beekman AM. Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical Communications. 2024;60(63):8228-8231. doi:10.1039/d4cc01249f
BibTeX
@article{Hayward2024,
author = {Hayward, Deanne and Goddard, Zoë R and Cominetti, Marco M D and Searcey, Mark and Beekman, Andrew M},
title = {Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction},
journal = {Chemical Communications},
year = {2024},
volume = {60},
number = {63},
pages = {8228--8231},
doi = {10.1039/d4cc01249f}
}
EUVIMED